↓ Skip to main content

Comparative efficacy of everolimus plus exemestane versus fulvestrant for hormone-receptor-positive advanced breast cancer following progression/recurrence after endocrine therapy: a network meta-analy…

Overview of attention for article published in Breast Cancer Research and Treatment, November 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

blogs
1 blog
policy
1 policy source

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
72 Mendeley